This study showed that out of 35 markers evaluated in a single sample taken 6 months prior to diagnosis in 118 women with ovarian cancer, HE4 (sensitivity 73%) was the second best marker to CA125 (sensitivity 86%). The gene discussed is WFDC2; the disease is ovarian cancer.